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Purpose: Absence from work due to mental disorders is substantial. Additionally, long-term 
absence from work is associated with a reduced probability of return-to-work (RTW). Major 
depressive disorder (MDD) is a prevalent condition in Dutch occupational health care settings. 
An early estimate of the prognosis regarding RTW in patients with MDD could serve both as a 
point of departure for the identification of high-risk cases and as an instrument to monitor the 
course of the disorder and of RTW. In the current study, we aimed to assess the added value of 
health-related quality of life (HRQoL) and severity of depression to predict the time to RTW.
Patients and methods: Data were derived from a prospective longitudinal study aimed to 
evaluate the cost effectiveness of a collaborative care treatment in sick-listed workers with MDD. 
We included demographic, job-related, and health-related variables. Severity of depression was 
measured using the Patient Health Questionnaire Depression Scale-9 (PHQ-9). HRQoL was 
measured using two generic preference-based instruments, the EuroQol 5-Dimension (EQ-5D™) 
and the Medical Outcomes Study Short Form Health Survey (SF-36). A survival model was 
constructed by applying different survival functions to assess the best fit for the data.  Additionally, 
survival analyses were performed to assess the added value of the two HRQoL measures and 
depression severity for predicting RTW.
Results: Females and older patients had a longer time to RTW. The same was true for patients 
with a full-time job and patients with more decision latitude. Patients in a management position 
and patients with more social support had a shorter time to RTW. Severity of depression was 
not predictive for the time to RTW. HRQoL measured by the SF-36 was a significant predictor 
for the time to RTW.
Conclusion: HRQoL emerged as a significant predictor for the time to RTW. However, severity 
of depression was not predictive for the time to RTW. These results suggest the importance of 
assessing HRQoL in addition to severity of disease to assess functionality.
Keywords: major depressive disorder, survival analyses, return-to-work, HRQoL
Introduction
The number of workers absent from work due to mental disorders such as depression 
is substantial in The Netherlands and in other Western countries.1–4 In a recent survey 
among workers in The Netherlands, the 1-year prevalence of depressive disorders was 
estimated at 4.2%.5 A study performed in the USA reported an average of 27.2 addi-
tional days of lost productivity due to absence from work or reduced work efficiency 
per year of workers with a depressive disorder.6 Based on data from The Netherlands 
Mental Health Survey and Incidence Study-2 (NEMESIS-2) it was estimated that 
 workers with a depressive disorder have an average of 22.8 additional days of absence 
from work per year.5 However, Flach et al7 found sick leave durations of more than 
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6 weeks in 62% of workers who were sick listed due to depres-
sive disorder in The Netherlands. Apart from the individual 
suffering of mental health problems, associated sick leave 
has several other negative consequences. Long-term absence 
from work is associated with a reduced probability of return-
to-work (RTW), which leads to a weakened financial position, 
social isolation, reduced quality of life, and exclusion from 
the labor market.8
Apart from these individual disadvantages, absence from 
work leads to an economic burden to society.9,10 An early 
estimate of the prognosis regarding RTW in patients with 
major depressive disorder (MDD) could serve both as a point 
of departure for the identification of high-risk cases and as an 
instrument to monitor the course of the disorder and of RTW.
In The Netherlands, the Gatekeeper Improvement Act 
requires employees at risk for long-term sickness absence 
to have contact with an occupational physician (OP) within 
6 weeks of absence from work. Consequently, the OPs have 
opportunities for treatment and prevention. The identifica-
tion of prognostic factors for patients at risk for long-term 
absence from work may facilitate the selection of patients 
who will most likely benefit from early interventions. Two 
recent systematic reviews of factors predicting RTW for 
people with poor mental health found that the factors ranged 
widely. For instance, factors were related to work (eg, job 
stress, threat of unemployment), health risk behaviors (eg, 
weight,  smoking, drug dependence), social status (eg, marital 
status, sex, education), and medical condition (eg, severity 
of symptoms). However, the authors also concluded that the 
definitions of poor mental health varied widely, that studies 
had sometimes produced opposing results, and that further 
research is needed.11,12
In a recent study, severity of depression was found to be 
an important independent predictive factor for more days of 
absence from work.13
Health-related quality of life (HRQoL) is a common 
outcome measure in economic evaluations. Two studies 
investigated how HRQoL influenced RTW in patients with 
somatic diseases. Elfving et al14 found that bodily pain and 
social functioning, measured as domains within the Medical 
Outcomes Study Short Form Health Survey (SF-36),15 were 
predictive of increased working time after a multidisciplinary 
rehabilitation program among long-term sickness absentees 
with spinal pain.
Clay et al16 found significant associations between high 
social functioning (as a domain in the SF-36) and strong 
social relationships and earlier RTW following acute unin-
tentional injuries.
No studies were found in which the prognostic value of 
preference-based HRQoL outcomes was evaluated in patients 
with mental disorders.
Hence, in the current study, we aimed to assess the added 
value of HRQoL and severity of depression alongside other 
factors to predict the time to RTW for workers listed as sick 
for at least 4 weeks due to MDD.
A priori, our hypotheses would be that a higher severity 
of depression and a lower HRQoL would lead to a longer 
time to RTW.
Material and methods
study sample
Data were derived from a prospective, longitudinal study, per-
formed as part of The Netherlands Depression Initiative17,18 
aimed to evaluate the cost effectiveness of a collaborative 
care treatment in sick-listed workers with MDD.19–21
The study was approved by the Medical Ethical Com-
mittee of the VU University Medical Centre, Amsterdam, 
The Netherlands. Recruitment was conducted in collaboration 
with a large Dutch occupational health service. Workers on 
sickness absence between 4 and 12 weeks were sent a ques-
tionnaire accompanied by written information about the study 
and an informed consent form. Respondents were screened 
on MDD using the Patient Health Questionnaire Depression 
Scale (PHQ-9, see below). Respondents who reached a cut-
off score of 10 (moderate to severe MDD) on the PHQ-9 were 
contacted to arrange an appointment for the administration of 
the Mini-International Neuropsychiatric Interview (MINI) to 
assess whether the respondent met the Diagnostic and Statis-
tical Manual of Mental Disorders, fourth edition (DSM-IV) 
criteria for MDD.22,23 Respondents were included if DSM-IV 
criteria for MDD were met and informed consent was given. 
Respondents with suicidal or psychotic symptoms or with 
a primary diagnosis of substance abuse or dependence, as 
assessed with the MINI interview, were excluded. A total of 
126 workers were eligible for the study, of whom 122 were 
still on sick leave at the time of baseline measurement. Of 
these, 59 received care as usual and 63 were treated with the 
collaborative care treatment. At baseline, these workers had 
been on sick leave for an average of 70 days. The dependent 
variable in this study is the duration until full RTW, derived 
from the Occupational Health Service registration, starting 
from the moment of baseline measurement. Full RTW was 
defined as the first full RTW with equal earnings, lasting for 
at least 4 weeks. In accordance with the Dutch Health Law, 
two sickness absence episodes with less than 4 weeks of full 
RTW in between were counted as a single absence episode. 
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Data were censored for workers whose sickness absence 
ended because they resigned from their job during the study 
(n = 15), and for workers who were still on sick leave at the 
end of the study (n = 14).
Baseline measurements included personal, job-related, 
and health-related data, including HRQoL measurements. 
Consequently, all data refer to the period before RTW.
Demographic measures
The personal information collected included demographic 
variables such as age, sex, living condition (ie, living alone, 
with an adult partner, with children, with parents), and 
education.
Job-related measures
Job-related information was measured with five scales 
from the Job Content Questionnaire (JCQ).24 The JCQ is a 
self-administered instrument that measures social and psy-
chological characteristics of jobs. The aspects measured are 
decision latitude (nine items), including the dimensions skill 
discretion and decision authority; psychological job demands 
(five items); physical job demands (five items), including 
physical exertion and physical isometric loads; social support 
(eight items), including co-worker and supervisor support; 
and job insecurity (three items).
Additionally, respondents were asked whether their job 
comprised a management function and the total number of 
working hours and days per week at the start of sick leave.
health-related measures
Health-related information included severity of depressive 
symptoms and somatization using the PHQ.25,26 The PHQ 
is a brief and reliable instrument that can be used to detect 
disorders in primary care. The depression scale of the PHQ, 
called the PHQ-9, ranges from 0 to 27. The somatization scale 
of the PHQ-15 ranges from 0 to 30. A higher score indicates 
a higher level of health problems. Additionally, self-reported 
co-morbid chronic disorders during the last 12 months were 
measured using a list derived from the Health Interview Sur-
vey of Statistics Netherlands (CBS) that contains 28 medical 
conditions.27 For each patient, the total number of chronic ill-
nesses they had was recorded. In this study, data were derived 
from patients participating in a randomized controlled trial to 
evaluate the effectiveness of collaborative care in comparison 
with usual care. In the case of comparable effectiveness of 
alternative interventions, as was the case in this study, treat-
ment groups may be combined.28 However, the PHQ-9 score 
was the outcome used in the effectiveness study. As the 
treatment may have impacted on the relationship between 
predictors and RTW, assignment to the alternative treatment 
interventions was added to the analyses as a covariate.
HRQoL was measured by two commonly applied generic 
preference-based measures, the EuroQol five-dimension 
(EQ-5D)29 and the Short Form-36 (SF-36).15 The EQ-5D is 
a validated instrument for measuring general HRQoL cover-
ing five dimensions of health, ie, mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression. Each 
dimension is rated on a three-point scale with categories 
‘no problems’, ‘some problems’, or ‘extreme problems’, 
resulting in a descriptive health profile. Respondents’ health 
profiles were valued using valuations derived from the general 
population in The Netherlands.30
The SF-36 consists of 36 questions, yielding an eight-
scale profile of health: general health, physical function-
ing, role limitations (role-physical and role-emotional), 
social functioning, bodily pain, vitality, and mental health. 
A preference-based index score, known as the SF-6D 
(Medical Outcomes Study Short Form-6 dimensions), was 
calculated using 11 items of the SF-36 and valuations from 
the general UK population.31
survival analysis
In this post hoc analysis, our aim was to calculate a survival 
model that would predict the number of days a sick worker 
would ‘survive’ in sick leave. We started with the definition 
of a survival model without covariates (Empty Model). We 
tested whether an exponential, Weibull, Gompertz, log-
normal, log-logistic, or generalized gamma survival function 
would provide the best fit for our data. In this study, model fit 
was measured using Akaike’s Information Criterion (AIC), 
Schwarz’s Bayesian Information Criterion (BIC), and the 
Log-likelihood. In the case of nested models, we performed 
a likelihood ratio test. Based on these results, we selected 
the optimal functional form and added covariates using the 
forward selection procedure. Every time a new variable was 
added, we tested whether variables that were included earlier 
could be discarded without change in the estimated median 
survival. This change was assessed using the absolute value 
of the difference in median survival between a model with, 
and a model without the variable. We considered a change 
in survival significant if the average change over all patients 
was more than 2 weeks. Groups of variables that were closely 
linked (eg, the different aspects of the JCQ) were added at 
the same time and then evaluated individually. Variables were 
always tested in different forms, for example, as a logarithm, 
as a dummy variable, or as a categorical variable. After the 
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researchers were satisfied with the fit of the model, we tested 
whether the chosen survival curve still had the best fit, or 
whether, including the covariates, a different survival curve 
would fit better. The resulting model was called the Full 
Model. Using this Full Model, we tested whether a measure 
of severity of MDD (the PHQ-9) or HRQoL (EQ-5D utility 
score and SF-6D utility index score) would provide added 
value when predicting RTW. We then performed an extra 
forward selection procedure to see whether variables that 
were discounted at an earlier stage were useful additions 
to the models including one of these three variables. The 
analyses were corrected for the duration of absence from 
work at entry into the study by adding this to the model as a 
covariate. The survival analyses were performed using Stata 
12.0 (Statacorp, College Station, TX, USA).
Results
A total of 122 patients were included, with a RTW ranging 
from approximately 1 week to 143 weeks (average 34 weeks). 
Median RTW for uncensored observations was 20.9 weeks. 
Characteristics of the study population are presented in 
Table 1. Approximately 55% were female; the average age was 
43.4 years (standard deviation [SD] 11.1). Two patients were 
aged above the Dutch pension age of 65 years. Female patients 
were on average 4 years younger than male (not shown). 
The patients in the population worked on average 35 hours 
per week before their sick leave started. Almost 60% of the 
patients (71) worked full-time (36 hours per week or more). 
Generally, female workers had fewer working hours than their 
male counterparts (31 and 38 hours per week,  respectively), 
which is in line with the Dutch working  population. 
A management position was held by 22% of patients. At 
baseline, the average PHQ-9 score was 16, which is classified 
as moderate severe MDD.25 The period between screening and 
inclusion into the study was, on average, 23 days. At baseline, 
the average utility score for the EQ-5D and the SF-6D was 
0.582 (SD 0.238) and 0.565 (SD 0.064), respectively.
Multicollinearity was assessed using a correlation matrix 
of all parameters. Of the available variables, only several 
within the JCQ showed a correlation larger than 0.5. This 
correlation was taken into account when assessing which 
combination of these parameters could be included in the 
Full Model due to multicollinearity. The three parameters of 
interest, PHQ-9, EQ-5D, and SF-6D, were also correlated, 
as would be expected.
Based on the AIC and BIC for the Empty Model, a 
log-normal survival function was preferred over the other 
calculated survival functions (see Table 2).
Based on the log-likelihood, the generalized gamma func-
tion would be preferable, but a likelihood ratio test found no 
statistically significant differences between the log-normal 
and the generalized gamma functions (P = 0.45). We therefore 
continued with a log-normal survival function. The resulting 
models are presented in Table 3.
The Full Model comprises personal, job-related, 
and physical health-related variables. A total number of 
116 observations, for which complete data were available, 
were used. The type of intervention that patients received 
was not predictive for the time to RTW. Female patients and 
older patients had a longer time to RTW than male patients 
and younger patients. Patients with a partner and no children 
Table 1 characteristics of the study population at baseline 
(n = 122)
sick leave in days: mean (range) 70 (35–155)
Personal variables
Female (%) 54
age: mean (range) 43.5 (21.5–71.3)
educational level (%)
 low 18.9
 Moderate 44.3
 high 35.3
 Unknown 1.6
Job-related variables
Working hours per week: mean (range) 33.8 (12–45)
Working days per week: mean (range) 4.5 (2–5)
holds a management position (%) 22
JcQ – skill discretion: mean (range) 34.6 (14–48)
JcQ – decision authority: mean (range) 31.5 (12–48)
JcQ – psychological job demands: mean (range) 35.1 (19–46)
JcQ – physical exertion: mean (range) 6.1 (3–12)
JcQ – posture/physical isometric loads: mean (range) 4.2 (2–8)
JcQ – job insecurity: mean (range) 7.9 (5–11)
JcQ – supervisor support: mean (range) 9.5 (4–14)
JcQ – co-worker support: mean (range) 11.6 (5–16)
Health-related variables
comorbidity (%) 
 hypertension 
  Inflammation of head cavities 
  Serious spinal affliction 
 Migraine
20.5 
13.1 
11.5 
10.7
PhQ-9: mean (range) 16.0 (0–27)
PhQ-15: mean (range) 13.1 (0–27)
eQ-5D: mean (range) 0.582  
(–0.058 to 1.000)
sF-6D: mean (range) 0.565  
(0.381–0.746)
Number of chronic illnesses: mean (range) 1.3 (0–6)
Notes: The educational levels ‘low’ and ‘moderate’ refer to different levels of general 
secondary education or pre-vocational secondary education. The educational level 
‘high’ refers to higher professional or academic education. skill discretion + decision 
authority = decision latitude; physical exertion + physical isometric loads = physical 
job demands; supervisor support + co-workers support = social support.
Abbreviations: eQ-5D, euroQol 5-Dimension; JcQ, Job content Questionnaire; 
PhQ-9, Patient health Questionnaire Depression scale-9; sF-6D, Medical Outcomes 
study short Form-6 dimensions.
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more severely depressed patients had a longer time to RTW, 
but this association was not significant at a 10% level. The 
present formulation, using the PHQ-9 directly, had the lowest 
AIC and BIC. Other formulations that were tested were the 
natural logarithm of the PHQ-9, the PHQ-9 divided in five 
classes, and as an indicator variable for moderate to severe 
depression (PHQ-9 $ 10). As expected from the small influ-
ence of this variable on the total RTW, the covariates were 
not changed compared with the Full Model.
Adding the SF-6D as a measure of HRQoL (SF-6D 
Model) significantly improved our model fit. The final formu-
lation used was the logarithm of 1 minus the SF-6D, meaning 
that the positive parameter value indicates that patients with a 
higher HRQoL had a shorter time to RTW. This is in line with 
our a priori hypothesis about the association between HRQoL 
and the time to RTW. Adding EQ-5D as a measure of the 
HRQoL to the Full Model (EQ-5D Model) slightly improved 
model fit, although the parameter itself was not significant 
at a 10% level. The best formulation for the EQ-5D was a 
logarithm. In Figure 1, survival curves based on the SF-6D 
Model are presented. The graph shows the percentage of 
patients (vertical axis) that would still ‘survive’ on sick leave 
after a number of weeks (horizontal axis). All covariates were 
taken at the average for the entire population used to estimate 
the survival curve. The three curves show the difference for a 
patient with a low (SF-6D = 0.381), average (0.570), and high 
(0.746) HRQoL. It clearly shows that a lower HRQoL leads 
Table 2 estimation results for several survival curves, no 
covariates
AIC BIC Log-likelihood (df)
exponential 330.83 333.64 -164.42 (1)
Weibull 330.38 335.99 -163.19 (2)
gompertz 332.67 338.28 -164.34 (2)
log-normal 325.39 331.00 -160.69 (2)
log-logistic 326.06 331.66 -161.03 (2)
generalized gamma 326.83 335.24 -160.42 (3)
Abbreviations: aic, akaike’s information criterion; Bic, Bayesian information 
criterion; df, degrees of freedom used in the likelihood ratio tests.
Table 3 estimation results for return-to-work after depression, using log-normal survival models
Full Model PHQ-9 Model EQ-5D Model SF-6D Model
Personal variables
 Female 0.868*** 0.886*** 0.852*** 0.716***
 age (in years) 0.028*** 0.029*** 0.030*** 0.022**
 living with adult partner, no children 0.433** 0.434** 0.438** 0.330*
Job-related variables
 holds a management function -0.635*** -0.616*** -0.642*** -0.643***
 Work week $36 hours 0.686*** 0.712*** 0.678*** 0.641***
 amount of decision latitude (JcQ) 0.018** 0.018** 0.019** 0.013
 amount of social support (JcQ) -0.075** -0.073** -0.063** -0.074***
intervention (collaborative care) -0.098 -0.084 -0.067 -0.255
health-related variables
 PhQ-9 at baseline 0.017
 eQ-5D at baseline (ln) -0.210
 sF-6D at baseline (ln)a 1.167*
constant 1.728** 1.281 1.180 3.540***
sigma (ln) -0.117 -0.123 -0.126 -0.148*
Number of observations 116 116 114 99
akaike’s information criterion (aic) 288.3 289.4 284.1 246.4
Bayesian information criterion (Bic) 315.9 319.7 314.2 274.9
Notes: aMeasured using the logarithm of 1 minus the sF-6D. *P , 0.1; **P , 0.05; ***P , 0.01.
Abbreviations: eQ-5D, euroQol 5-Dimension; JcQ, Job contents Questionnaire; ln, natural logarithm; PhQ-9, Patient health Questionnaire Depression scale-9; sF-6D, 
Medical Outcomes study short Form-6 dimensions.
had an increased time to RTW in comparison to patients 
with other living conditions. Marital status and educational 
level were not found to be predictive of the time to RTW. 
Patients in a management position predicted a shorter time 
to RTW. A full-time job was a predictor of a longer time to 
RTW. The same was true for patients who had more decision 
latitude. Social support, from both their supervisor and their 
coworkers, resulted in less time to RTW. Other job-related 
variables, including other JCQ variables, were not found to 
be predictive for the time to RTW. Health-related variables, 
in the form of somatic comorbidities and the PHQ-15 scores, 
were not found to be significantly predictive for the time 
to RTW.
Adding depression severity (PHQ-9 Model) to the Full 
model did not improve the model fit, as seen by a higher 
AIC and BIC. The parameter was positive, meaning that 
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to a longer time until RTW. The median time until RTW for 
a patient with average HRQoL is approximately 30 weeks, 
for a patient with low HRQoL almost 50 weeks, and for a 
patient with high HRQoL approximately 15 weeks.
Discussion
In this study, we have shown that HRQoL measures emerged 
as predictors of the time to RTW: workers with a worse 
HRQoL needed more time to RTW than those with a better 
HRQoL. This relationship was statistically significant using 
the SF-6D. Using the EQ-5D as a measure of HRQoL did 
lead to a better model fit, but the estimated coefficient was 
not significant at a 10% level. As opposed to what has been 
found previously,13 severity of depression was not a predictor 
of the time to RTW.
The better fit of the EQ-5D Model and SF-6D Model was 
expressed in a lower AIC and BIC. However, it was also 
apparent that these models were calculated on fewer observa-
tions than the Full Model. For two observations, no EQ-5D 
value was available and 17 observations were missing for the 
SF-6D. To test the influence of these missing observations on 
our model, we calculated the Full Model, the EQ-5D Model, 
and the SF-6D Model on the 99 observations that had all 
necessary information. We concluded that adding the EQ-5D 
leads to an increase in AIC and BIC (and thus worsening 
of fit), instead of a decrease as seen previously. Adding the 
SF-6D to the Full Model still leads to an improvement of 
model fit. From this, we may conclude that the predictive 
value of the preference scores based on the EQ-5D may be 
even less strong than our primary results seem to suggest. The 
different predictive values of the EQ-5D and SF-6D scores 
may be explained by the different classification systems and 
the different dimensions of these instruments. Grieve et al32 
indicated that the inclusion of items for vitality and social 
functioning of the SF-6D may partly explain the difference 
between the EQ-5D and the SF-6D.
However, more research, with different and especially 
more data, is necessary to corroborate these findings.
We have tested several covariates in the model that were 
found not to be predictive for the time to RTW. Educational 
level did not have any predictive value for the time to RTW. 
Neither the PHQ-15 scores nor the self-reported physical 
comorbidity were significantly predictive of the time to RTW. 
Nielsen et al33 found no significant association between sex, 
education, or cohabitation and the time to RTW in employees 
with mental health problems. A systematic review in patients 
suffering from poor mental health by Blank et al11 showed 
that a wide range of factors predict RTW and opposing 
results were found for older age and sex in predicting RTW. 
However, in the review by Cornelius et al,12 strong evidence 
0
20
40
60
80
10
0
P
er
ce
n
ta
g
e 
o
n
 s
ic
k 
le
av
e
0 50 100 150
Time (weeks)
Low HRQoL (SF-6D=0.381) Average HRQoL (SF-6D=0.570)
High HRQoL (SF-6D=0.746)
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Abbreviations: hrQol, health-related quality of life; sF-6D, Medical Outcomes study short Form-6 dimensions.
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was found that older age was associated with time to RTW, 
and limited evidence was reported for other demographic, 
health-, or job-related factors in workers with mental 
disorders. Lagerveld et al2 conducted a review and found 
inconclusive evidence for demographic factors (eg, sex, 
age, education, and marital status), and moderate evidence 
for the presence of comorbid mental or physical disorders, 
severity of depressive disorder, and age being associated 
with duration of absence from work in depressed workers. As 
opposed to what was found earlier,13 severity of depressive 
symptoms, as measured by the PHQ-9, was not predictive 
for the time to RTW in our study. This is somewhat surpris-
ing, as severity of depression generally correlates with other 
outcomes. However, it was also shown that patients with 
clinically significant symptom improvement still exhibited 
persistent impairment in functioning.8
However, the comparison with other studies is hampered 
due to the use of different instruments to assess severity of 
depression and variations in methodological designs and 
stuvdy populations.
For the patients in our study, the duration of sick leave 
before baseline measurement ranged from 35 to 155 days, 
with an average of 70 days. The influence of differences in 
these sick leave episodes was examined using the days of 
sick leave before baseline measurement as a covariate in 
the full model. We did not find a significant influence of 
this on predicting time to RTW. Vlasveld et al34 examined 
associations of factors and RTW in workers on sickness 
absence due to all causes of illness. Significant factors 
found in this study were high physical job demands, high 
physical symptoms, and older age. Additionally, Vlasveld 
et al34 found that moderate to severe depression was asso-
ciated with a longer time to RTW. Differences with our 
findings can be attributable to four reasons. First, the study 
populations differ. In the current study, the study population 
consists of employees on sick leave due to MDD, while the 
study population of Vlasveld et al34 consisted of workers 
on sick leave due to any cause of illness. Second, Vlasveld 
et al34 used a Cox Proportional Hazard function, which does 
not require a parametric functional form for survival. 
The extra limitation of imposing a functional form as the 
log-normal in our study is necessary in order to calculate 
median survival. Further, Vlasveld et al34 only used cova-
riates on a dichotomous scale. We tested all variables in 
different forms, which might influence the effect of the 
PHQ-9. Finally, the data in Vlasveld et al34 were censored 
after 1 year of observation. We only censored observations 
if absence ended due to resignation and if absence was not 
ended at the time of the study. Apart from throwing away 
valuable information, this may lead to bias in survival 
analysis.
Our study has several limitations. Any available informa-
tion from the time before inclusion was limited to information 
based on occupational registrations. Lagerveld et al2 found 
strong evidence for an association between work disability 
and longer duration of depression.
However, we did not have information about the duration 
of MDD before the start of sick leave. Additionally, we did not 
have information about other variables that may contribute to 
the time to RTW, eg, psychiatric comorbidity, pharmacologic 
treatment of MDD, or previous depressive episodes. Other 
relevant factors that may contribute to RTW that were not 
included in this study are occupational factors such as the 
size of the enterprise and levels of occupational health staff, 
and individual factors such as health behaviors and family 
situations. More research is recommended to fully evaluate 
the relevant contributing factors of RTW. The findings in our 
study apply only to patients with moderate or severe depres-
sion, as patients with mild depression at the time of screening 
were not invited to participate in this study. Additionally, 
only patients who had already been on sick leave for at least 
4 weeks were included. Although MDD is generally associ-
ated with relatively long episodes of sick leave, this may limit 
the generalizability of our findings to all patients with MDD. 
Additionally, the validity of the PHQ-9 as an instrument to 
measure depression severity is still under discussion.35 More 
research is recommended using alternative instruments to 
measure severity of MDD. Another limitation concerns the 
sample size of the study. The sample size limits the number 
of variables that can be taken into account. Applying larger 
sample sizes may result in additional significant predictors 
of RTW. Several studies report on the predictive value of 
depression on RTW in comparison with populations without 
a depressive disorder.33,34
To our knowledge, our study is the first to explore the 
influence of factors of severity of MDD and HRQoL on RTW 
in a population with MDD.
Conclusion
Our study showed that RTW was not significantly associated 
with severity of depression. However, HRQoL, measured with 
the SF-6D, was a significant predictor of the time to RTW. 
These results suggest the importance of assessing HRQoL in 
addition to severity of MDD to assess functionality.
Neuropsychiatric Disease and Treatment 2013:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1644
Vemer et al
Acknowledgment
The study was supported f inancially by Laboratoire 
 Lundbeck, France. This study used data that was collected 
in the Depression Initiative, funded by Innovatiefonds 
Zorgverzekeraars.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Lerner D, Henke R. What does research tell us about depression, job 
performance, and work productivity? J Occup Environ Med. 2008;50(4): 
401–410.
 2. Lagerveld S, Bültmann U, Franche RL, et al. Factors associated with 
work participation and work functioning in depressed workers: a sys-
tematic review. J Occup Rehabil. 2010;20(3):275–292.
 3. Henderson M, Glozier N, Holland Elliott K. Long term sickness absence. 
BMJ. 2005;330(7495):802–803.
 4. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs 
of depressive illness in a major US corporation. Am J Psychiatry. 
2000;157(8):1274–1278.
 5. de Graaf R, Tuithof M, van Dorsselaer S, ten Have M. Sick Leave 
due to Psychological and Somatic Disorders among Workers. Results 
of the ‘Netherlands Mental Health Survey and Incidence Study-2’ 
(NEMESIS-2). Utrecht: Netherlands Institute of Mental Health and 
Addiction; 2011. Dutch.
 6. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood 
disorders on work performance in a nationally representative sample 
of US workers. Am J Psychiatry. 2006;163(9):1561–1568.
 7. Flach PA, Groothoff JW, Krol B, Bültmann U. Factors associated with 
first return to work and sick leave durations in workers with common 
mental disorders. Eur J Public Health. 2012;22(3):440–445.
 8. Dekkers-Sánchez PM, Hoving JL, Sluiter JK, Frings-Dresen MH. 
Factors associated with long-term sick leave in sick-listed employees: 
a systematic review. Occup Environ Med. 2008;65(3):153–157.
 9. van Roijen LH, van Straten A, Al M, Rutten F, Donker M. Cost-utility 
of brief psychological treatment for depression and anxiety. Br J 
 Psychiatry. 2006;188:323–329.
 10. Krol M, Papenburg J, Koopmanschap M, Brouwer W. Do productiv-
ity costs matter? The impact of including productivity costs on the 
incremental costs of interventions targeted at depressive disorders. 
Pharmacoeconomics. 2011;29(7):601–619.
 11. Blank L, Peters J, Pickvance S, Wilford J, Macdonald E. A systematic 
review of the factors which predict return to work for people suffer-
ing episodes of poor mental health. J Occup Rehabil. 2008;18(1): 
27–34.
 12. Cornelius LR, van der Klink JJ, Groothoff JW, Brouwer S. Prognostic 
factors of long term disability due to mental disorders: a systematic 
review. J Occup Rehabil. 2011;21(2):259–274.
 13. Hees HL, Koeter MW, Schene AH. Predictors of long-term return 
to work and symptom remission in sick-listed patients with major 
 depression. J Clin Psychiatry. 2012;73(8):e1048–e1055.
 14. Elfving B, Asell M, Ropponen A, Alexanderson K. What factors predict 
full or partial return to work among sickness absentees with spinal 
pain participating in rehabilitation? Disabil Rehabil. 2009;31(16): 
1318–1327.
 15. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health sur-
vey (SF-36). I. Conceptual framework and item selection. Med Care. 
1992;30(6):473–483.
 16. Clay FJ, Fitzharris M, Kerr E, McClure RJ, Watson WL. The association 
of social functioning, social relationships and the receipt of compen-
sation with time to return to work following unintentional injuries to 
Victorian workers. J Occup Rehabil. 2012;22(3):363–375.
 17. de Jong FJ, van Steenbergen-Weijenburg KM, Huijbregts KM, et al. 
The depression initiative. Description of a collaborative care model for 
depression and of the factors influencing its implementation in the pri-
mary care setting in The Netherlands. Int J Integr Care. 2009;9:e81.
 18. van der Feltz-Cornelis CM. Towards integrated primary health care for 
depressive disorder in The Netherlands. The depression initiative. Int J 
Integr Care. 2009;9:e83.
 19. Vlasveld MC, van der Feltz-Cornelis CM, Adèr HJ, et al. Collaborative 
care for major depressive disorder in an occupational healthcare setting. 
Br J Psychiatry. 2012;200(6):510–511.
 20. Vlasveld MC, Anema JR, Beekman AT, et al. Multidisciplinary collab-
orative care for depressive disorder in the occupational health setting: 
design of a randomised controlled trial and cost-effectiveness study. 
BMC Health Serv Res. 2008;8:99.
 21. Vlasveld MC, van der Feltz-Cornelis CM, Adèr HJ, et al.  Collaborative 
care for sick-listed workers with major depressive disorder: a ran-
domised controlled trial from The Netherlands Depression Initiative 
aimed at return to work and depressive symptoms. Occup Environ Med. 
2013;70(4):223–230.
 22. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International 
Neuropsychiatric Interview (MINI): the development and validation of 
a structured diagnostic psychiatric interview for DSM-IV and ICD-10. 
J Clin Psychiatry. 1998;59 Suppl 20:22–33.
 23. Vliet vI, Beurs dE. [The MINI-International Neuropsychiatric Interview. 
A brief structured diagnostic psychiatric interview for DSM-IV en 
ICD-10 psychiatric disorders.] Tijdschr Psychiatr. 2007;49(6):393–397. 
Dutch.
 24. Karasek R, Brisson C, Kawakami N, Houtman I, Bongers P, Amick B. 
The Job Content Questionnaire (JCQ): an instrument for internation-
ally comparative assessments of psychosocial job characteristics. J Occ 
Health Psychol. 1998;3(4):322–355.
 25. Kroenke K, Spitzer RL, Williams JB. The PHQ-9. Validity of a brief 
depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
 26. Kroenke K, Sptitzer RL, Williams JB. The PHQ-15: validity of a new 
measure for evaluating the severity of somatic symptoms. Psychosom 
Med. 2002;64(2):258–266.
 27. Questionnaires Health Inquiry 2010 [webpage on the Internet]. Den 
Haag: Statistics Netherlands (CBS); 2010. Available from: http://
www.cbs.nl/nl-NL/menu/themas/gezondheid-welzijn/methoden/ 
dataverzameling/overige-dataverzameling/2011-ge2010-vragenlijsten.
htm. Accessed August 16, 2012.
 28. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. 
 Prognosis and prognostic research: what, why, and how? BMJ. 
2009;338:b375.
 29. Brooks R. EuroQol: The current state of play. Health Policy. 1996; 
37(1):53–72.
 30. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. 
[Measuring the quality of life in economic evaluations: the Dutch 
EQ-5D tariff.] Ned Tijdschr Geneeskd. 2005;149(28):1574–1578. 
Dutch.
 31. Brazier J, Roberts J, Deverill M. The estimation of a preference- 
based measure of health from the SF-36. J Health Econ. 2002;21(2): 
271–292.
 32. Grieve R, Grishchenko M, Cairns J. SF-6D versus EQ-5D: reasons for 
differences in utility scores and impact on reported cost-utility. Eur J 
Health Econ. 2009;10(1):15–23.
 33. Nielsen MB, Bültmann U, Madsen IE, et al. Health, work, and personal-
related predictors of time to return to work among employees with 
mental health problems. Disabil Rehabil. 2012;34(15):1311–1316.
 34. Vlasveld MC, van der Feltz-Cornelis CM, Bültmann U, et al. 
 Predicting return to work in workers with all-cause sickness absence 
greater than 4 weeks: a prospective cohort study. J Occup Rehabil. 
2012;22(1):118–126.
 35. Zimmerman M, Martinez JH, Friedman M, Boerescu DA, Attiullah N, 
Toba C. How can we use depression severity to guide treatment selec-
tion when measures of depression categorize patients differently? 
J Clin Psychiatry. 2012;73(10):1287–1291.
Neuropsychiatric Disease and Treatment
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journal
Neuropsychiatric Disease and Treatment is an international, peer-
reviewed journal of clinical therapeutics and pharmacology focusing 
on concise rapid reporting of clinical or pre-clinical studies on a 
range of neuropsychiatric and neurological disorders. This journal 
is indexed on PubMed Central, the ‘PsycINFO’ database and CAS. 
The manuscript management system is completely online and includes 
a very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
Neuropsychiatric Disease and Treatment 2013:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
1645
survival analysis on the return-to-work after depression
